Drug: FENTANYL TRANSDERMAL SYSTEM Injury: Product substitution issue Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
117138662 | FENTANYL TRANSDERMAL SYSTEM | Product substitution issue | APOTEX | 0.00 | F | 0 | 20160721 | US |
125611971 | FENTANYL TRANSDERMAL SYSTEM | Product substitution issue | APOTEX | 0.00 | F | 0 | 20160715 | US |
125613991 | FENTANYL TRANSDERMAL SYSTEM | Product substitution issue | APOTEX | 0.00 | M | 0 | 20160715 | US |
125682781 | FENTANYL TRANSDERMAL SYSTEM | Product substitution issue | APOTEX | 89.76 YR | F | 0 | 20160718 | US |
125733771 | FENTANYL TRANSDERMAL SYSTEM | Product substitution issue | 68.00 YR | M | 0 | 20160719 | US | |
126402211 | FENTANYL TRANSDERMAL SYSTEM | Product substitution issue | WATSON | 59.00 YR | F | 0 | 20160810 | US |
Total Records: 6 Number of Pages: 1